Clinical Trial Update: A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AZD0901 as monotherapy in adults with 2L+ advanced or metastatic gastric or GEJ adenocarcinoma expressing CLDN18.2. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• AZD0901

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING